Table 1.
The antimicrobial susceptibility patterns of P. aeruginosa isolates
| Antibiotics | N (%) of isolates (n=85) | ||
|---|---|---|---|
| S | I | R | |
| Ceftazidime | 29 (34.11) | 12 (14.11) | 44 (51.76) |
| Aztreonam | 42 (49.41) | 17 (20) | 26 (30.59) |
| Imipenem | 71 (83.52) | 0 | 14 (16.47) |
| Meropenem | 77 (90.58) | 0 | 8 (9.41) |
| Amikacin | 69 (81.17) | 4 (4.7) | 12 (14.12) |
| Gentamicin | 53 (62.35) | 2 (2.35) | 30 (35.29) |
| Tobramycin | 56 (65.88) | 1 (1.17) | 28 (32.94) |
| Piperacillin/Tazobactam | 77 (90.58) | 0 | 8 (9.41) |
| Ciprofloxacin | 57 (67.05) | 8 (9.41) | 20 (23.5) |
| Levofloxacin | 42 (49.41) | 15 (17.64) | 28 (32.9) |
| Ticarcillin | 52 (61.17) | 5 (5.88) | 28 (32.94) |
| Polymyxin B | 85 (100) | 0 | 0 |
S, susceptible; I, intermediate; R, resistant